ity of kallikrein appears to be mediated through the enzymatic generation of the polypeptide bradykinin (4) , whereas the mechanism of PF/dil's action is still uncertain. The role of the permeability globulins in the biology of living organisms is not entirely known. Bradykinin is one of the most potent vasodilator substances known (5) . It not only causes vasodilation and increased vascular permeability, but produces pain and the local accumulation of leukocytes (6) , and therefore has been suggested as a mediator of the inflammatory response. The permeability globulins have not as yet been implicated directly in the pathogenesis of a known human disease; however, there is evidence to indicate that a basic defect in the genetically determined disease hereditary angioneurotic edema is the lack of a permeability globulin inhibitor (7) . Kallikrein may, in addition, have a hormonal role in bringing about the functional vasodilatation of actively secreting salivary glands and the heat vasodilatation of skin (8) . Further, hypotensive vasodilator substances similar to, bradykinin have been evoked in tissues by axon reflex (9) . It (1) .
bean trypsin inhibitor (10) (11) (12) . Because of these similarities, it has been suggested that PF/dil and kallikrein are the same (13) . PF/dil, however, is in some instances not a kininogenase (14) . Moreover, Miles has reported PF/dil to be an a,-globulin in the guinea pig, whereas Davies and Lowe (15) have shown DFP-inhibitable permeability activity in the y-globulin portion of activated guinea-pig serum. Whether there is more than one permeability globulin in this species, or whether these differences are due to artifacts of the different preparative procedures the previous reports leave unclear. We wish to report separation of two permeability globulins from human serum by the use of starch-block electrophoresis and column chromatography.
METHODS
Blood samples were drawn under sterile conditions from normal male donors into plastic syringes or tubing and then transferred to glass centrifuge vessels, where they were kept at room temperature (about 24°C) for 1 to 2 hours. Formed clots were then rimmed with sterile wooden applicator sticks and separated from serum by centrifugation at 50 C. Samples of serum were stored frozen at -15°C.
Five-molar diisopropyl phosphofluoridate (DFP); soybean trypsin inhibitor crystallized 5 times; 2 diphenhydramine hydrochloride,3 10 mg per ml as an antihistaminic agent; Nair,4 containing calcium thioglycollate, as a depilatory substance before bioassay; and 6BX Pontamine Sky Blue5 were used.
Bioassay of permeability activity was done by injecting 0.2 ml of a given solution intradermally into white, Detrick-Hartley guinea pigs, weighing 300 to 400 g, that had received an iv injection of 0.5 ml of a solution of 3 g Pontamine Sky Blue per 100 ml 15 minutes before. The method is adapted from that of Miles Preparative starch-block electrophoresis was carried out in the manner described by Kunkel and Slater (19) . Potato starch 7washed and resuspended in electrophoresis buffer (barbital at pH 8.6, s 0.05) was the medium. The block was contained in a 31-X 20-X 1.5-cm Lucite mold with three narrow channels created by the insertion of Lucite partitions, making it possible to run three samples simultaneously, under the same conditions. The samples were applied in troughs 1 cm wide and 1 cm deep; details of applied current and sample size are noted in appropriate figure legends. Plastic bags filled with crushed ice were placed over and under the block during the run to prevent internal overheating. At the end of the run, the block was cut into segments that were then mechanically stirred with equal volumes of 0.15 M NaCl. The resulting supernatant fluids were assayed for protein concentration and bioactivity. Initially, dialysis to remove residual barbital buffer was performed before a test of permeability activity. There was, however, no difference in bioactivity between dialyzed and undialyzed eluates, so dialysis was not performed in later electrophoretic experiments.
Fractionation of whole serum was performed at -5°C by method 10 of Cohn and associates (20 Fractional cuts are 1 cm wide. See Methods for scale of lesion size. Serum I: 8.5 ml, origin = segment 11, 500 v, 70 ma, 15 hours; II: 11.0 ml, origin = segment 13, 600 v, 50 to 70 ma, 14 hours; III: 11.0 ml, origin = segment 12, 600 v, 100 ma., 151 hours; IV: 7.0 ml, origin = segment 13, 600 v, 100 to 120 ma, 18 hours; and V: 4.8 ml, origin = segment 13, 600 v, 100 to 120 ma, 18 hours. activity of starch-block eluates can be seen in l)road, merging zones extending from the y-to the /8-globulins. A major portion or peak of activity in each of these cases has moved with the ,/-globulins, while another portion seems to reside principally in the "fast" y-globulin zone. These results indicate not only the possibility of recovering permeability globulins from preparative electrophoresis, but suggest the presence of more than one globulin permeability factor. Figure 2 explore this possibility, ion-exchange chromatography of whole serum was carried out. DEAE-cellulose column chron2atographic patterns of protein concentration and permeability activity of normal human sera. Figure 3 shows the results obtained by DEAE-cellulose chromatographic separation of the sera of two young men. (These are the same sera as sera III and IV, Figure 1 .) The dotted line in the figures represents the rising ionic strength, plotted in units of electrical conductivity; the unbroken line is a plot of protein concentration. In both samples, an initial protein peak representing chiefly the serum y-globulins with little binding affinity for the they were originally derived. It can be seen that the permeability activity of A moved backward from the origin with the y-globulins. The permeability activity of B moved toward the anode with the /3-globulins. The original sample of pooled serum demonstrated an activity pattern that could be well accounted for, then, by its content of A and B. Also, B has a slightly greater mobility after the purification procedures than it had in whole serum.
Rechromatography of A and B after electrophoresis. The activity of A, recovered from the starch block by elution with 0.15 M saline, was bioassayed and applied to a DEAE-cellulose column. Chromatography was carried out as shown in Figure 7 , which shows a single peak of activity (A) in the same position (at 0.007 mhos) as A occupies in whole serum. Recovery and rechromatography were similarly done for B. Figure 8 shows the single peak of activity eluting from the column at a conductivity of 0.110 mhos. This is similar to its chromato- Table IV indicate no inhibition of the activity of A or B by diphenhydramine. Diphenhydramine did, however, inhibit the histamine-induced permeability effect. 
DISCUSSION
Serum of normal young men contains two, nondialyzable, ethanol-precipitable, permeability globulins that differ from each other in their electrophoretic mobility and chromatographic behavior. They were prepared after ethanol fractionation by chromatographic separation followed by electrophoresis and rechromatography. Globulin A has the mobility of serum y-globulin, while B has that of /-globulin. Both globulin factors are inhibited by DFP and soybean trypsin inhibitor, suggesting the probable enzymatic nature of both A and B. Whether these substances are both esterases as has been described for PF/dil and kallikrein is not yet certain.
Globulin A has no affinity for DEAE cellulose, and is absorbed on carboxymethyl cellulose under the same conditions (22) Miles found that human PF/dil had the mobility of 8-globulin (14) . It 
